Bifogade filer
Kurs
+1,15%
Likviditet
0,02 MSEK
Prenumeration
Kalender
Tid* | ||
2025-05-08 | N/A | Årsstämma |
2025-05-08 | 08:30 | Kvartalsrapport 2025-Q1 |
2025-02-14 | 08:30 | Bokslutskommuniké 2024 |
2024-11-08 | - | Kvartalsrapport 2024-Q3 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-05-10 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2024-05-10 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2024-05-08 | - | Årsstämma |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-16 | - | Bokslutskommuniké 2023 |
2023-11-10 | - | Kvartalsrapport 2023-Q3 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2023-05-05 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2023-05-04 | - | Årsstämma |
2023-05-04 | - | Kvartalsrapport 2023-Q1 |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-11-11 | - | Kvartalsrapport 2022-Q3 |
2022-08-25 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2022-05-06 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2022-05-05 | - | Årsstämma |
2022-04-27 | - | Kvartalsrapport 2022-Q1 |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-11-12 | - | Kvartalsrapport 2021-Q3 |
2021-08-20 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2021-05-06 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2021-05-05 | - | Årsstämma |
2021-04-27 | - | Kvartalsrapport 2021-Q1 |
2021-02-16 | - | Bokslutskommuniké 2020 |
2020-11-10 | - | Kvartalsrapport 2020-Q3 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-05-13 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2020-05-13 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2020-05-04 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-18 | - | Årsstämma |
2020-02-13 | - | Årsstämma |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-10-25 | - | Årsstämma |
2019-08-22 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2019-05-07 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2019-05-06 | - | Årsstämma |
2019-05-03 | - | Kvartalsrapport 2019-Q1 |
2019-02-18 | - | Extra Bolagsstämma 2019 |
2019-02-13 | - | Bokslutskommuniké 2018 |
2018-11-20 | - | Kvartalsrapport 2018-Q3 |
2018-08-24 | - | Kvartalsrapport 2018-Q2 |
2018-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2018-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2018-05-03 | - | Årsstämma |
2018-04-30 | - | Kvartalsrapport 2018-Q1 |
2018-02-08 | - | Bokslutskommuniké 2017 |
2017-11-21 | - | Kvartalsrapport 2017-Q3 |
2017-08-22 | - | Kvartalsrapport 2017-Q2 |
2017-05-12 | - | Extra Bolagsstämma 2017 |
2017-05-02 | - | Kvartalsrapport 2017-Q1 |
2017-05-02 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2017-05-02 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2017-04-28 | - | Årsstämma |
2017-02-10 | - | Bokslutskommuniké 2016 |
2016-10-24 | - | Kvartalsrapport 2016-Q3 |
2016-07-13 | - | Kvartalsrapport 2016-Q2 |
2016-05-09 | - | Årsstämma |
2016-05-02 | - | Kvartalsrapport 2016-Q1 |
2016-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2016-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2016-02-10 | - | Bokslutskommuniké 2015 |
2015-10-20 | - | Kvartalsrapport 2015-Q3 |
2015-07-13 | - | Kvartalsrapport 2015-Q2 |
2015-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2015-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2015-04-29 | - | Årsstämma |
2015-04-29 | - | Kvartalsrapport 2015-Q1 |
2015-02-17 | - | Bokslutskommuniké 2014 |
2014-10-27 | - | Kvartalsrapport 2014-Q3 |
2014-07-11 | - | Kvartalsrapport 2014-Q2 |
2014-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2014-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2014-04-29 | - | Årsstämma |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-02-07 | - | Bokslutskommuniké 2013 |
2013-10-18 | - | Kvartalsrapport 2013-Q3 |
2013-07-12 | - | Kvartalsrapport 2013-Q2 |
2013-04-30 | - | Kvartalsrapport 2013-Q1 |
2013-04-22 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2013-04-22 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2013-04-19 | - | Årsstämma |
2013-02-08 | - | Bokslutskommuniké 2012 |
2012-10-18 | - | Kvartalsrapport 2012-Q3 |
2012-07-12 | - | Kvartalsrapport 2012-Q2 |
2012-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2012-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2012-05-03 | - | Årsstämma |
2012-04-20 | - | Kvartalsrapport 2012-Q1 |
2012-02-22 | - | Bokslutskommuniké 2011 |
2011-10-14 | - | Kvartalsrapport 2011-Q3 |
2011-08-12 | - | Kvartalsrapport 2011-Q2 |
2011-05-31 | - | Extra Bolagsstämma 2010 |
2011-05-05 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2011-05-05 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2011-05-04 | - | Årsstämma |
2011-04-15 | - | Kvartalsrapport 2011-Q1 |
2011-02-18 | - | Bokslutskommuniké 2010 |
2010-10-14 | - | Kvartalsrapport 2010-Q3 |
2010-08-12 | - | Kvartalsrapport 2010-Q2 |
2010-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2010-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2010-05-03 | - | Årsstämma |
2010-04-22 | - | Kvartalsrapport 2010-Q1 |
2010-02-19 | - | Bokslutskommuniké 2009 |
2009-11-12 | - | Kvartalsrapport 2009-Q3 |
2009-08-14 | - | Kvartalsrapport 2009-Q2 |
2009-05-07 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2009-05-07 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2009-05-06 | - | Årsstämma |
2009-05-06 | - | Kvartalsrapport 2009-Q1 |
1998-04-23 | - | Split ORTI A 1:2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
The second quarter was characterized by our major delivery projects and transformation efforts.
Significant events for the period April - June 2024
- The contract for the delivery of MobiMed ePR to Region Norrbotten has been signed by both parties. It covers all of the region’s ambulance vehicles and has a duration of five years, with the possibility of annual extensions for an additional five years. The estimated order value is 6.0 MSEK for the initial period, with an additional 4.5 MSEK upon contract extension.
- Region Örebro län has awarded Ortivus a contract for the delivery of MobiMed enRoute to the region’s ambulance service. The value of the delivery is estimated at 8.3 MSEK, with a contract duration of 5 years and the possibility of annual extensions for an additional 5 years.
Significant events after end of the period
- Joanna Daffy Tiitus has chosen to step down from her role as Marketing and Communications Manager at Ortivus, as well as her position as a member of the company’s management team.
- Ortivus has recruited Johan Wewel as the new Chief Financial Officer and member of the company’s management team.
- Ortivus has expanded its credit facility agreement with its main shareholder, Ponderus Invest. The new credit facility now totals 25 MSEK, of which 10 MSEK has been utilized.
April - June 2024
- Net sales amounted to 17.7 (20.7) MSEK.
- The gross margin amounted to 30% (37%).
- The net income after tax amounted to -8.3 (-4.8) MSEK.
- Earnings after tax per share before and after dilution amounted to -0.19 (-0.11) SEK.
- Operating cash flow before changes in working capital amounted to -8.8 (-4.3) MSEK.
January - June 2024
- Net sales amounted to 39.7 (48.7) MSEK.
- The gross margin amounted to 36% (43%).
- The net income after tax amounted to -10.5 (-4.6) MSEK.
- Earnings after tax per share before and after dilution amounted to -0.24 (-0.10) SEK.
- Operating cash flow before changes in working capital amounted to -9.4 (-2.8) MSEK.
Apr-Jun 2024 | Apr-Jun 2023 | Jan-Jun 2024 | Jan-Jun 2023 | Jan-Dec 2023 | |
Net sales (MSEK) | 17.7 | 20.7 | 39.7 | 48.7 | 84.7 |
Gross margin (%) | 30% | 37% | 36% | 43% | 37% |
Operating profit (MSEK) | -7.8 | -4.7 | -9.9 | -4.2 | -17.6 |
Operating margin (%) | -44% | -23% | -25% | -9% | -21% |
EBITDA (MSEK) | -7.7 | -3.5 | -9.1 | -2.0 | -11.9 |
Contacts
For further information, please contact
Gustaf Nordenhök, CEO
Telefon +46 8 446 45 00
About Ortivus
Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.
MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.
MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.
Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
Read more about Ortivus at www.ortivus.com
This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-08-23 08:30 CEST.